Center for Scientific Review; Notice of Closed Meeting, 76477-76478 [2010-30818]
Download as PDF
Federal Register / Vol. 75, No. 235 / Wednesday, December 8, 2010 / Notices
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Dated: December 2, 2010.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
National Institutes of Health
[FR Doc. 2010–30810 Filed 12–7–10; 8:45 am]
Notice is hereby given of a change in
the meeting of the Center for Scientific
Review Special Emphasis Panel,
December 28, 2010, 8 a.m. to December
29, 2010, 5 p.m., National Institutes of
Health, 6701 Rockledge Drive, Bethesda,
MD 20892 which was published in the
Federal Register on November 29, 2010,
75 FR 73114–73115.
The meeting will be held January 6,
2011 to January 7, 2011. The meeting
time and location remain the same. The
meeting is closed to the public.
Center for Scientific Review; Amended
Notice of Meeting
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of General Medical
Sciences; Notice of Closed Meeting
jlentini on DSKJ8SOYB1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
General Medical Sciences Special Emphasis
Panel MBRS Score Grant Applications
Review.
Date: December 21, 2010.
Time: 1 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building, 45 Center Drive, Room
3AN18, Bethesda, MD 20892. (Telephone
Conference Call).
Contact: Lisa Dunbar, PhD, Scientific
Review Officer, Office of Scientific Review,
National Institute of General Medical
Sciences, National Institutes of Health, 45
Center Drive, Room 3AN12, Bethesda, MD
20892. 301–594–2849. dunbarl@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.375, Minority Biomedical
Research Support; 93.821, Cell Biology and
Biophysics Research; 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.862, Genetics and
Developmental Biology Research; 93.88,
Minority Access to Research Careers; 93.96,
Special Minority Initiatives, National
Institutes of Health, HHS)
Dated: December 2, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2010–30825 Filed 12–7–10; 8:45 am]
BILLING CODE 4140–01–P
VerDate Mar<15>2010
18:23 Dec 07, 2010
Jkt 223001
76477
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: December 2, 2010.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2010–30821 Filed 12–7–10; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Dated: December 2, 2010.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
National Institutes of Health
[FR Doc. 2010–30823 Filed 12–7–10; 8:45 am]
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflicts: CIMG and GMPB.
Date: December 21, 2010.
Time: 12 p.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Patricia Greenwel, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2178,
MSC 7818, Bethesda, MD 20892, 301–435–
1169. greenwep@csr.nih.gov.
PO 00000
Frm 00085
Fmt 4703
Sfmt 4703
Center for Scientific Review; Notice of
Closed Meeting
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Auditory and Vestibular
Neuroscience.
Date: December 13, 2010.
Time: 1 p.m. to 2:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call)
Contact Person: John Bishop, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5182,
MSC 7844, Bethesda, MD 20892, (301) 408–
9664, bishopj@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
E:\FR\FM\08DEN1.SGM
08DEN1
76478
Federal Register / Vol. 75, No. 235 / Wednesday, December 8, 2010 / Notices
Dated: December 2, 2010.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2010–30818 Filed 12–7–10; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood
Institute; Amended Notice of Meeting
Notice is hereby given of a change in
the meeting of the National Heart, Lung,
and Blood Institute Special Emphasis
Panel, December 14, 2010, 8 a.m. to
December 14, 2010, 2 p.m., Doubletree
Hotel Bethesda (Formerly Holiday Inn
Select), 8120 Wisconsin Avenue,
Bethesda, MD 20814 which was
published in the Federal Register on
November 17, 2010, FR2010–28981.
The meeting location changed from
Doubletree Hotel Bethesda to Hyatt
Regency Bethesda, 7400 Wisconsin
Avenue, Bethesda, MD 20814. The
meeting is closed to the public.
Dated: December 2, 2010.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2010–30816 Filed 12–7–10; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of
Meetings
jlentini on DSKJ8SOYB1PROD with NOTICES
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of meetings of the AIDS
Research Advisory Committee, NIAID.
The meetings will be open to the
public, with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
Name of Committee: AIDS Research
Advisory Committee, NIAID.
Date: February 7, 2011.
Time: 1 p.m. to 5:30 p.m.
Agenda: Reports from the Division Director
and other staff.
Place: National Institutes of Health,
Natcher Building, 45 Center Drive,
Conference Rooms E1/E2, Bethesda, MD
20892.
VerDate Mar<15>2010
18:23 Dec 07, 2010
Jkt 223001
Contact: Rona L. Siskind, Executive
Secretary, AIDS Research Advisory
Committee, Division of AIDS, NIAID/NIH,
6700B Rockledge Drive, Room 4139,
Bethesda, MD 20892–7601. 301–435–3732.
Name of Committee: AIDS Research
Advisory Committee, NIAID.
Date: May 23, 2011.
Time: 1 p.m. to 5 p.m.
Agenda: Reports from the Division Director
and other staff.
Place: National Institutes of Health,
Natcher Building, 45 Center Drive,
Conference Rooms E1/E2, Bethesda, MD
20892.
Contact: Rona L. Siskind, Executive
Secretary, AIDS Research Advisory
Committee, Division of AIDS, NIAID/NIH,
6700B Rockledge Drive, Room 4139,
Bethesda, MD 20892–7601. 301–435–3732.
Name of Committee: AIDS Research
Advisory Committee, NIAID.
Date: September 19, 2011.
Time: 1 p.m. to 5 p.m.
Agenda: Reports from the Division Director
and other staff.
Place: National Institutes of Health,
Natcher Building, 45 Center Drive,
Conference Rooms E1/E2, Bethesda, MD
20892.
Contact: Rona L. Siskind, Executive
Secretary, AIDS Research Advisory
Committee, Division of AIDS, NIAID/NIH,
6700B Rockledge Drive, Room 4139,
Bethesda, MD 20892–7601. 301–435–3732.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: December 2, 2010.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2010–30808 Filed 12–7–10; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Mandatory Guidelines for Federal
Workplace Drug Testing Programs
Substance Abuse and Mental
Health Services Administration,
AGENCY:
PO 00000
Frm 00086
Fmt 4703
Sfmt 4703
Department of Health and Human
Services.
ACTION: HHS Approval of Entities That
Certify Medical Review Officers
(MROs).
The recent revisions to the
Department of Health and Human
Services (HHS) Mandatory Guidelines
for Federal Workplace Drug Testing
Programs (Mandatory Guidelines) which
took effect on October 1, 2010 address
the role and qualifications of Medical
Review Officers (MROs) and HHS
approval of entities that certify MROs.
Subpart M–Medical Review Officer
(MRO), Section 13.1(b), ‘‘Who may serve
as an MRO?’’ states as follows:
‘‘Nationally recognized entities that
certify MROs or subspecialty boards for
physicians performing a review of
Federal employee drug testing results
that seek approval by the Secretary must
submit their qualifications and a sample
examination. Based on an annual
objective review of the qualifications
and content of the examination, the
Secretary shall publish a list in the
Federal Register of those entities and
boards that have been approved.’’
HHS has completed its review of
entities that train and certify MROs, in
accordance with requests submitted by
such entities to HHS.
(1) The HHS Secretary approves the
following MRO certifying entities that
offer both MRO training and
certification through examination:
American Association of Medical
Review Officers (AAMRO), P.O. Box
12873, Research Triangle Park, NC
27709. Phone: (800) 489–1839, Fax:
(919) 490–1010, E-mail:
cferrell@aamro.com. Web site: https://
www.aamro.com/.
Medical Review Officer Certification
Council (MROCC), 836 Arlington
Heights Road, #327, Elk Grove
Village, IL 60007. Phone: (847) 631–
0599, Fax: (847) 483–1282, E-mail:
mrocc@mrocc.org. Web site: https://
www.mrocc.org/.
(2) The HHS Secretary approves the
following entities that offer MRO
training as a prerequisite for MRO
certification:
American College of Occupational and
Environmental Medicine (ACOEM),
25 Northwest Point Boulevard, Suite
700, Elk Grove Village, IL 60007–
1030, Phone: (847) 818–1800, Fax:
(847) 818–9266, Contact Form:
https://www.acoem.org/
contactacoem.aspx. Web site: https://
www.acoem.org/.
American Society of Addiction
Medicine (ASAM), 4601 N. Park
Avenue, Upper Arcade #101, Chevy
SUMMARY:
E:\FR\FM\08DEN1.SGM
08DEN1
Agencies
[Federal Register Volume 75, Number 235 (Wednesday, December 8, 2010)]
[Notices]
[Pages 76477-76478]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-30818]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Auditory and Vestibular Neuroscience.
Date: December 13, 2010.
Time: 1 p.m. to 2:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Telephone Conference Call)
Contact Person: John Bishop, PhD, Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 5182, MSC 7844, Bethesda, MD 20892, (301) 408-
9664, bishopj@csr.nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
[[Page 76478]]
Dated: December 2, 2010.
Jennifer S. Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2010-30818 Filed 12-7-10; 8:45 am]
BILLING CODE 4140-01-P